Russian investment funds to get green light on crypto derivatives

來源 Cryptopolitan

Russia’s central bank intends to permit funds to invest in derivatives based on crypto assets, a representative of its management has indicated.

The goal is to admit management companies to the growing market, as currently only brokers provide qualified investors with access to such instruments.

Bank of Russia to give funds access to cryptocurrency derivatives in 2026

The Central Bank of Russia (CBR) plans to allow investment funds to acquire crypto derivatives and is likely to do that next year, RBC reported, quoting one of its top executives.

Valery Krasinsky, deputy head of the bank’s Investment Finance Intermediation Department, made the announcement during the Capital Markets 2025 forum, organized by the Russian business news outlet.

Speaking on the sidelines of the event, Krasinsky explained:

“Indeed, we plan to level the playing field with brokers and allow settlement derivative financial instruments on cryptocurrency, on digital currencies [for management companies].”

In May of this year, the CBR issued a circular authorizing financial institutions to launch crypto derivatives on the Russian market. A number of firms immediately came up with various offerings, as reported by Cryptopolitan.

These products, such as futures contracts on the shares of leading exchange-traded funds (ETFs) tracking the price of Bitcoin (BTC), are currently sold by brokers.

In July, the Bank of Russia made it clear it’s open to permitting management firms to buy crypto assets for mutual fund portfolios. However, it didn’t set a deadline for when this might happen.

Maintaining that access to crypto assets should be limited, the regulator proposed in March a special “experimental legal regime” allowing “highly qualified” investors to trade coins and derivatives.

Both companies and individuals can fit in that category, but private citizens need to prove investments in securities and deposits exceeding 100 million rubles or income from the past year of more than 50 million rubles (approximately $1.2 million and $600,000, respectively).

The monetary authority is developing separate requirements for financial institutions that want to invest in cryptocurrencies directly, taking into account associated risks.

Only qualified investors to have access to crypto funds

It is expected that only highly qualified investors will be able to invest in funds with crypto assets, RBC noted in its report.

According to Valery Krasinsky, several regulatory obstacles must be removed to make that possible, besides adjusting rules governing mutual funds. He elaborated:

“It’s also necessary to introduce a list of base assets for derivative financial instruments on cryptocurrency.”

The CBR official highlighted that a draft regulatory act has been prepared already, adding that it’s likely to be adopted in 2026.

Krasinsky also commented he would be surprised if this leads to the emergence of new large investment funds, emphasizing he would prefer the classic stock and bond market to remain prevalent in Russia.

The news of the CBR’s upcoming regulatory move comes after Russian authorities recently indicated they are ready to carefully expand investor access to crypto assets.

Earlier in September, the Ministry of Finance suggested easing the requirements for granting the status of “highly qualified” investor.

Speaking during the recently held Eastern Economic Forum, the head of the ministry’s Financial Policy Department, Alexey Yakovlev, said the strict criteria “can be adjusted downwards,” adding that the matter is being discussed now.

KEY Difference Wire helps crypto brands break through and dominate headlines fast

免責聲明:僅供參考。 過去的表現並不預示未來的結果。
placeholder
黃金七連漲終結!是上車機會還是牛市拐點?​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
作者  投資-槓把子
9 月 05 日 週五
​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
placeholder
康霈*減重藥遭FDA一拳重擊!股價跳空跌停 賣單高掛上萬張 散戶集體出逃?​投資慧眼Insights-因減肥藥進展受阻,生技股康霈*(6919)今(10)日早盤開盤即跌停鎖死在229.5元,暴跌10%。
作者  投資指南針
昨日 03: 15
​投資慧眼Insights-因減肥藥進展受阻,生技股康霈*(6919)今(10)日早盤開盤即跌停鎖死在229.5元,暴跌10%。
placeholder
康霈*澄清來得太遲!1.5萬張賣單說明一切:一場由減肥藥夢碎引發的踩踏遠未結束生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
作者  投資-槓把子
昨日 06: 35
生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
placeholder
黃金、白銀繼續衝高,澳新銀行:2025年底金價將漲至3800美元!2025年底,金價有望漲至3800美元,銀價可望漲至50美元。
作者  Tony Chou
昨日 08: 57
2025年底,金價有望漲至3800美元,銀價可望漲至50美元。
placeholder
生技股王殞落! FDA重擊+內部人狂賣,康霈*遭連續兩日跌停康霈*生技新藥研發進程突生變數,引發市場劇烈反應。這家不久前剛被納入台灣五十指數成分股的生技明星企業,在9月9日法說會上宣布,其核心產品減肥注射劑CBL-514的臨床三期試驗將延後約半年收案,導致公司股票連續兩個交易日跌停,市值蒸發400億元,跌停板委賣張數累計超過3萬張。
作者  投資-槓把子
11 小時前
康霈*生技新藥研發進程突生變數,引發市場劇烈反應。這家不久前剛被納入台灣五十指數成分股的生技明星企業,在9月9日法說會上宣布,其核心產品減肥注射劑CBL-514的臨床三期試驗將延後約半年收案,導致公司股票連續兩個交易日跌停,市值蒸發400億元,跌停板委賣張數累計超過3萬張。
goTop
quote